ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2690 • 2012 ACR/ARHP Annual Meeting

    Assessment of Sleep Quality in Patients with Rheumatoid Arthritis

    Ulku Ucar and Mehmet Tuncay Duruöz, PMR Department, Rheumatology Division, Celal Bayar University Medical School, Manisa, Turkey

    Background/Purpose: Rheumatoid arthritis is a chronic inflammatory disease affecting mainly diartrodial synovial joints. Fatigue and sleep disturbances are commonly seen symptoms in RA patients  which…
  • Abstract Number: 2692 • 2012 ACR/ARHP Annual Meeting

    Diet and Other Lifestyle Related Factors and the Risk of Developing Rheumatoid Arthritis

    Björn Sundström1, Ingegerd Johansson2 and Solbritt Rantapää Dahlqvist3, 1Department of Public Health & Clinical Medicine, Rheumatology, Umeå University, Umeå, Sweden, 2Department of Odontology, Cariology, Umeå Universitet, Umeå, Sweden, 3Department of Public Health and Clinical Medicine/Rheumatology, Umeå University Hospital, Umeå, Sweden

    Background/Purpose: There is a growing interest in the role of lifestyle in developing chronic diseases, such as rheumatoid arthritis (RA). Our aim was to investigate…
  • Abstract Number: 2693 • 2012 ACR/ARHP Annual Meeting

    Factors Associated with Person-Perceived Disability in Adults Aged 18+ with Rheumatoid Arthritis

    Yeliz Greenhill1, Alison Hammond2 and Sarah Tyson1, 1Centre for Health Sciences Research, University of Salford, Manchester, United Kingdom, 2Centre for Health Sciences Research, University of Salford, Greater Manchester, United Kingdom

    Background/Purpose: Rheumatoid Arthritis (RA) is associated with high risk of disability (1). Loss of independence is negatively correlated with the person’s health and wellbeing (2).…
  • Abstract Number: 2694 • 2012 ACR/ARHP Annual Meeting

    Examination of a Multidimensional Model of Disability and Role Functioning in Patients with Rheumatoid Arthritis

    Sarah R. Ormseth1, Taylor Draper2, M. Custodio3, Michael H. Weisman4, M.R. Irwin5 and Perry M. Nicassio5, 1Cousins Center for PNI, University of California, Los Angeles, Los Angeles, CA, 2Psychology, Loma Linda University, Loma Linda, CA, 3UCLA, Los Angeles, CA, 4Cedars-Sinai Medical Center, Los Angeles, CA, 5Cousins Center for PNI, UCLA, Los Angeles, CA

    Background/Purpose: Disability and impairments in role functioning are common obstacles for many patients with RA. A combination of disease-related and psychosocial factors may contribute to…
  • Abstract Number: 2670 • 2012 ACR/ARHP Annual Meeting

    Genome-Wide Association Study On the Severity of Joint Destruction in Autoantibody Positive Rheumatoid Arthritis Identifies a Role for Sperm Associated Antigen 16

    Rachel Knevel1, Kerstin Klein2, Klaartje Somers3, Caroline Ospelt4, Jeanine J. Houwing-Duistermaat5, Jessica van Nies6, Diederik P.C. de Rooy6, Laura de Bock7, Joris Schonkeren8, Gerrie Stoeken-Rijsbergen6, Jenna Kiridly9, Luis Rodriguez-Rodriguez9, Quinta Helmer5, Piet Sinissen3, Tom W. J. Huizinga1, René E.M. Toes1, Steffen Gay10, Peter K. Gregersen11, Veerle Somers7 and Annette H.M. van der Helm - van Mil8, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Center of Experimental Rheumatology, University Hospital Zurich and Zurich Center of Integrative Human Physiology (ZIHP),, Zurich, Switzerland, 3Hasselt University, Biomedical Research Institute, Diepenbeek, Belgium, 4Center of Experimental Rheumatology, University Hospital Zurich and Zurich Center of Integrative Human Physiology (ZIHP), Switzerland, Zurich, Switzerland, 5Department of Medical Statistics and Bioinformatics, Leiden, Netherlands, 6Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 7Hasselt University, Biomedical Research Institute, Belgium, 8Leiden University Medical Center, Leiden, Netherlands, 9Feinstein Institute for Medical Research and North Shore–Long Island Jewish Health System, Manhasset, New York, 10Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland, 11Genomics and Human Genetics, Feinstein Institute for Medical Research, Manhasset, NY

    Background/Purpose: Recent genome-wide association studies (GWAs) have identified >30 SNPs predisposing to Rheumatoid Arthritis (RA). These variants are helpful in unraveling the pathogenesis of RA.…
  • Abstract Number: 2658 • 2012 ACR/ARHP Annual Meeting

    Correlation Between Mefv Genotype and Interleukin (IL)1β secretion and Role of the nlr Family Pyrin Domain Containing 3 (Nlrp3) Inflammasome in Patients with Familial Mediterranean Fever (FMF)

    Alessia Omenetti1, Sonia Carta2, Delfino Laura2, Alberto Martini3, Anna Rubartelli4 and Marco Gattorno1, 1Pediatrics II Unit G Gaslini Institute, Genoa, Italy, 2Cell Biology, lST-San Martino, Genoa, Italy, 3Pediatric Rheumatology Collaborative Study Group [PRSCG], Cincinnati, OH, 4lST-San Martino, Genoa, Italy, Genoa, Italy

    Background/Purpose: Familial Mediterranean Fever (FMF) is an autoinflammatory disease due to mutations of MEFV gene which encodes for Pyrin. FMF does not behave as a…
  • Abstract Number: 2659 • 2012 ACR/ARHP Annual Meeting

    An Expanded Repertoire of Anti-Citrullinated Peptide Antibodies Is Associated with Interstitial Lung Disease in Rheumatoid Arthritis

    Jon T. Giles1, Sonye Danoff2, Jeremy Sokolove3, Robert Winchester4, Dimitrios A. Pappas5, Catriona Cramb6, Geoffrey Connors7, Stanley S. Siegelman8, William H. Robinson9 and Joan M. Bathon5, 1Medicine, Columbia University, New York, NY, 2Medicine/Pulmonary, Johns Hopkins School of Medicine, Baltimore, MD, 3Medicine, VA Palo Alto Health Care System and Stanford University, Palo Alto, CA, 4Dept of Medicine & Pathology, Columbia University, New York, NY, 5Columbia University, New York, NY, 6VA Palo Alto Heatlh Care System and Stanford University, Palo Alto, CA, 7Division of Pulmonary and Critical Care Medicine, Yale University, New Haven, CT, 8Department of Radiology, Johns Hopkins University, Baltimore, MD, 9Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA

    Background/Purpose: Interstitial lung disease (ILD) is an outcome with high morbidity and mortality in rheumatoid arthritis (RA).  Citrullinated proteins are observed in these lung tissues;…
  • Abstract Number: 2660 • 2012 ACR/ARHP Annual Meeting

    Progressive Radiographic Joint Damage in Established Rheumatoid Arthritis: Common and Strongly Associated with Seropositivity

    Siri Lillegraven1, Nancy A. Shadick2, Zarif Jabbar-Lopez3, Anna Potapov3, Michelle A. Frits4, Christine K. Iannaccone4, Espen A. Haavardsholm1, Tore K. Kvien5, Michael Weinblatt2 and Daniel H. Solomon6, 1Diakonhjemmet Hospital, Oslo, Norway, 2Brigham and Women's Hospital, Boston, MA, 3Harvard School of Public Health, Boston, MA, 4Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 5Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 6Division of Rheumatology, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: During the last decade, rheumatoid arthritis (RA) research has mainly focused on early disease, as it has become apparent that early and aggressive treatment…
  • Abstract Number: 2661 • 2012 ACR/ARHP Annual Meeting

    Disease Activity Score 28-Joint Count: Are Erythrocyte Sedimentation Rate and C-Reactive Protein Versions Comparable?

    Roy Fleischmann1, Désirée van der Heijde2, Andrew S. Koenig3, Ronald Pedersen3, Annette Szumski4, Lisa Marshall5 and Eustratios Bananis4, 1Southwestern Medical Center at Dallas, University of Texas, Dallas, TX, 2Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Specialty Care, Pfizer Inc, Collegeville, PA, 4Specialty Care, Pfizer Inc., Collegeville, PA, 5Pfizer Inc., Collegeville, PA

    Background/Purpose: Frequently DAS28-CRP is utilized instead of DAS28-ESR to assess rheumatoid arthritis (RA) disease activity; however, values for remission and low disease activity (LDA) for…
  • Abstract Number: 2633 • 2012 ACR/ARHP Annual Meeting

    Independence At Home: Real or Perceived

    Hazel L. Breland, Health Professions, Division of Occupational Therapy, Medical University of South Carolina, Charleston, SC

    Background/Purpose: Rheumatic conditions are more prevalent among women than men and increase with age. Over 4 million African Americans affected are by rheumatic conditions and…
  • Abstract Number: 2634 • 2012 ACR/ARHP Annual Meeting

    Physical Disability, Perceived Dependence and Depression in Older Women with Osteoarthriti

    Kisoo Park1, Monique A. Gignac2 and E. M. Badley3, 1Preventive Medicine and Institute of health science, Gyeongsang National University, Jinju, South Korea, 2Divison of Health Care & Outcomes Research, Arthritis Community Research and Evaluation Unit , Toronto Western Research Institute and University of Toronto, Toronto, ON, Canada, 3Division of Health Care and Outcomes Research,Toronto Western Research Institute; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Older women with osteoarthritis (OA) often report difficulty with tasks and needing to rely on others for assistance. In addition, depressed mood has been…
  • Abstract Number: 2635 • 2012 ACR/ARHP Annual Meeting

    Exploring the Influence of Patient Perceptions On Medication Escalation in Daily Practice

    Jos Hendrikx1, Wietske Kievit2, Jaap Fransen2 and Piet L.C.M. van Riel2, 1Rheumatology (470), Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

    Background/Purpose: In rheumatoid arthritis (RA), patients' and physicians' perceptions of disease can differ and patients who are satisfied with their health do not tend to…
  • Abstract Number: 2636 • 2012 ACR/ARHP Annual Meeting

    Understanding Why Treat-to-Target Strategies Are Difficult to Follow

    Liana Fraenkel1, Meaghan Cunningham2 and Paul Falzer3, 1Medicine, Section of Rheumatology, Yale University School of Medicine, Veterans Affairs Connecticut Healthcare System, New Haven, CT, 2Medicine, Yale University School of Medicine, New Haven, CT, 3Medicine, VA Connecticut Healthcare System, New Haven, CT

    Background/Purpose: Treat-to-target (T2T) refers to a set of decision strategies widely advocated for the optimal management of rheumatoid arthritis (RA). Despite considerable evidence that this…
  • Abstract Number: 2637 • 2012 ACR/ARHP Annual Meeting

    Cost-Effectiveness and Cost-Utility Analysis of Treat-to-Target Versus Usual Care in Early Rheumatoid Arthritis: Results of the Dutch Rheumatoid Arthritis Monitoring Registry

    Marloes Vermeer1, Wietske Kievit2, Ina H. Kuper3, Annemarie Braakman-Jansen4, Hein J. Bernelot Moens5, Theo R. Zijlstra6, Alfons A. den Broeder7, Piet L.C.M. van Riel2, Jaap Fransen2 and Mart A.F.J. van de Laar1, 1University of Twente & Medisch Spectrum Twente, Enschede, Netherlands, 2Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 3Medisch Spectrum Twente, Enschede, Netherlands, 4Psychology & Communication, University of Twente, Enschede, Netherlands, 5Ziekenhuisgroep Twente, Hengelo, Netherlands, 6Isala Klinieken, Zwolle, Netherlands, 7Rheumatology, Maartenskliniek, Nijmegen, Netherlands

    Cost-Effectiveness and Cost-Utility Analysis of Treat-to-Target Versus Usual Care in Early Rheumatoid Arthritis: Results of the Dutch Rheumatoid Arthritis Monitoring RegistryBackground/Purpose: Treat-to-target (T2T) has proven…
  • Abstract Number: 2638 • 2012 ACR/ARHP Annual Meeting

    Biologic Switching Among Patients with Rheumatoid Arthritis in the United States, 2004-2011

    Ozgur Tunceli1, Jeffrey R. Curtis2, Tatia C. Woodward3, Siting Zhou1, Yen-Wen Chen4 and Ancilla W. Fernandes3, 1HealthCore, Inc., Wilmington, DE, 2Rheumatology & Immunology, Univ of Alabama-Birmingham, Birmingham, AL, 3MedImmune, LLC, Gaithersburg, MD, 4HealthCore, Inc, Wilmington, DE

    Background/Purpose: While studies have assessed the efficacy of switching among biologic disease-modifying antirheumatic drugs (bDMARD), there is a lack of knowledge regarding the patterns of…
  • « Previous Page
  • 1
  • …
  • 2426
  • 2427
  • 2428
  • 2429
  • 2430
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology